MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bugs vs. fatty liver: can a probiotic pill help?
Disease control Not yet recruitingThis study is testing whether a specific mix of probiotic supplements can improve liver health in people with a common type of fatty liver disease linked to being overweight. For 6 months, 60 participants will take either the probiotic or a placebo pill daily. Researchers will us…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: AB Biotics, SA • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can an 8-Hour eating window reverse fatty liver?
Disease control Not yet recruitingThis study will test if a time-restricted eating pattern helps people with fatty liver disease. 150 participants will either follow an 8-hour daily eating window with fruits and vegetables eaten only during daylight hours, or receive standard dietary advice. Researchers will comp…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Cyprus University of Technology • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can a spoonful of olive oil a day melt away liver fat?
Disease control Not yet recruitingThis study is testing whether adding extra virgin olive oil to a Mediterranean diet can help people with fatty liver disease (MASLD). Researchers will compare the effects of a standard amount (3 tablespoons) to a higher amount (9 tablespoons) daily over about 10 weeks. They will …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Can a computer alert help doctors spot serious liver disease?
Disease control Not yet recruitingThis study is testing a computer tool that alerts doctors when a patient with fatty liver disease might need to see a specialist or get more tests. It will involve 7,200 adults and compare whether the tool helps get patients the right care faster than usual methods. The goal is t…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Can an 8-Hour eating window shrink your liver fat?
Disease control Not yet recruitingThis study is testing if a daily eating schedule can help reduce fat in the liver. People with obesity and fatty liver disease will try eating all their food within an 8-hour window each day for 12 weeks, without counting calories. Researchers will use MRI scans to see if this ti…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Could a One-Time procedure reset your Body's sugar control?
Disease control Not yet recruitingThis study is testing a new, one-time endoscopic procedure called ReCET for people whose type 2 diabetes is not well-controlled with pills. The goal is to see if treating the first part of the small intestine (duodenum) can improve blood sugar levels and reduce fat in the liver. …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for a hidden liver problem in people with HIV
Disease control Not yet recruitingThis study is testing if a drug called resmetirom can safely reduce harmful fat buildup in the livers of people who have both HIV and a related fatty liver disease (MASLD). About 120 adults with well-controlled HIV and confirmed MASLD will take either the real drug or a placebo p…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Naga P. Chalasani • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Heart scan AI spots silent liver threat
Diagnosis Not yet recruitingThis study is testing whether artificial intelligence (AI) can find early signs of fatty liver disease by analyzing routine heart ultrasound images. It will enroll 2000 adults who have already had a heart scan. The main goal is to see if this AI tool helps doctors diagnose liver …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Kaiser Permanente • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Scientists probe Gut's role in silent liver epidemic
Knowledge-focused Not yet recruitingThis study aims to understand how gut bacteria might contribute to fatty liver disease (MASLD) by producing specific substances. Researchers will analyze stool and blood samples from 24 participants—some with MASLD and some healthy—to measure these bacterial products and identify…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Hidden liver threat in diabetes patients under investigation
Knowledge-focused Not yet recruitingThis study aims to find out how common and severe fatty liver disease is in adults living with type 1 diabetes in Quebec. Researchers will measure liver fat and scarring in 100 participants during a single visit to see if weight plays a role. The goal is to identify people who ma…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC